Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2011-10-21 Declaration of Voting R…
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
BOVIE 8-K RE 2011 ANNUAL MEETING
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filing dated October 18, 2011, reporting on the annual meeting of stockholders of Bovie Medical Corporation. It details the submission of matters to a vote of security holders, including election of directors, approval of a share incentive plan, and ratification of auditors. The content focuses on the official results of shareholder votes at the annual meeting. The document length is 3514 characters, which is relatively short and contains voting results, not the full AGM materials or presentations. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2011-10-21 English
BOVIE 8-K RE STOCKHOLDER DERIVATIVE
Legal Proceedings Report Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated September 19, 2011. It reports a stockholder derivative lawsuit filed against the company and certain officers and directors. The content focuses on legal proceedings and the company's response to the complaint. There are no financial statements, earnings data, or management discussion of financial results. The document is a regulatory announcement about a legal matter, not a full audit report or annual report. Therefore, it fits best under Legal Proceedings Report (LTR). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS. Hence, the classification is LTR with high confidence.
2011-09-23 English
Regulatory Filings 2011
Regulatory Filings Classification · 90% confidence The document text appears to be a binary or encoded file content (likely a PDF or similar) embedded in the text, with no clear readable financial or corporate disclosure information. There are no explicit references to report titles, fiscal periods, regulatory bodies, or specific filing types. The length is 8234 characters, which is substantial, but the content is not human-readable or interpretable as a financial or corporate report. Given the lack of discernible content and the nature of the text, this document does not fit into any specific detailed filing category. Therefore, it should be classified under the fallback category for miscellaneous or unclassifiable filings, which is Regulatory Filings (RNS).
2011-09-20 English
BOVIE 10Q/A
Interim / Quarterly Report Q1 2011
2011-09-19 English
13G
Major Shareholding Notification
2011-09-15 English
BOVIE AMENDMENT NO. 1 TO PROXY STATEMENT
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled 'Amendment No. 1 to Proxy Statement' and is filed on Schedule 14A, which is a proxy statement filing with the SEC. It relates to the 2011 Annual Meeting of Stockholders for Bovie Medical Corporation. The content includes details about the meeting date, voting matters (election of directors, approval of share incentive plan, ratification of auditors), voting instructions, and solicitation information. It is an amendment to a definitive proxy statement, not the proxy statement itself or the voting results. The document is not an annual report, earnings release, or any other financial report. It is clearly a proxy solicitation document, which corresponds to the category 'Proxy Solicitation & Information Statement' (PSI). The document length is substantial (15,000 characters), indicating it is the actual proxy statement amendment, not just a brief announcement. Therefore, the correct classification is PSI with high confidence.
2011-09-12 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.